Please login to the form below

Not currently logged in
Email:
Password:

US team reveals mechanism of drug breakdown enzyme

Researchers reveal atomic level structural details of an enzyme system which aids in the breakdown of drugs and toxins in the human body, a development which could lead to safer drugs in the future

Researchers at the University of Michigan have revealed atomic level structural details of an enzyme system which aids in the breakdown of many drugs and toxins in the human body.

The work could lead to the development of safer drugs in the future.

Research published in the online US journal BBA Biomembranes has shown that two proteins work cooperatively to rid the body of toxic chemicals. Cytochrome P450 is mainly involved, but only when its action is boosted by a second protein, cytochrome b5.

Both proteins interact only when they are bound to a cell membrane, which renders traditional techniques, such as X-ray crystallography, ineffective at highlighting the structural details of the interaction.

Crystallography is currently used to determine protein structures, but in order to do this the molecules must be separated from their membrane environment, says Ayyalusamy Ramamoorthy, head of the research group and associate professor of chemistry and biophysics.

As cytochrome b5 adheres to the cell membrane, separations break the molecule from its adherence point on the membrane, the structure of which controls its interaction with cytochrome P450. Thus, crystallography cannot provide insights into the mechanism of the interaction between P450 and b5.

To resolve this problem, Ramamoorthy's team used solid state NMR spectroscopy, which can produce detailed images of proteins in the membrane environment and reveal molecular structure. The technique also shows how a particular protein joins to the cell membrane.

More work is in progress to determine the detailed high-resolution structures of these two proteins, as well as other membrane-associated proteins which include many biologically important molecules.

Ramamoorthy said: "These proteins are involved in all major diseases, everywhere in the body, and are therefore primary targets for pharmaceutical applications. In my opinion, solving the structures of membrane proteins should be the highest priority for structural biologists in the coming years."

Ramamoorthy added that the research at the University of Minnesota will expand through plans to set up a high magnetic field solid-state NMR spectrometer facility and an NIH-funded programme.

17th September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics